![Donald Wuchterl](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Donald Wuchterl
Directeur/Membre du Conseil chez ABEONA THERAPEUTICS INC.
Fortune : 329 275 $ au 31/05/2024
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Michael Amoroso | M | 46 | 4 ans | |
Vishwas Seshadri | M | 48 | 3 ans | |
Christine Silverstein | F | 41 | 8 ans | |
Amanda Moore | F | - | 4 ans | |
Greg Gin | M | - | 4 ans | |
Mark Alvino | M | 56 | 3 ans | |
Brendan OMalley | M | 55 | 5 ans | |
Joseph Vazzano | M | 40 | 2 ans | |
Leila Alland | M | 61 | 3 ans | |
Faith Charles | F | 62 | 3 ans | |
Fulvio Mavilio | M | - | 7 ans | |
Igor Grachev | M | 63 | 3 ans | |
Brian Kevany | M | - | 6 ans | |
Carl Denny | M | - | 3 ans | |
Alison Hardgrove | F | - | 2 ans | |
Madhav Vasanthavada | M | - | - | |
Laura Brege | F | 66 |
T-Knife Therapeutics, Inc.
| 3 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Matt Patterson | M | 52 | 8 ans | |
Jesse McCool | M | - |
Cytovance Biologics, Inc.
![]() Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | - |
Thomas Schuetz | M | 63 | 8 ans | |
Stephen P. Squinto | M | 67 | 3 ans | |
Yan Wang | M | - |
Cytovance Biologics, Inc.
![]() Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | - |
Edward Conner | M | 51 | 2 ans | |
Louis Lange | M | 72 | 5 ans | |
Jodie Gillon | F | - | 2 ans | |
Kush Parmar | M | 42 | 5 ans | |
Mark Goldberg | M | 69 | 3 ans | |
Scott Morrison | M | 66 | 5 ans | |
Julie Smith | F | 53 | 4 ans | |
Thomas Woiwode | M | 52 | 4 ans | |
Steve H. Rouhandeh | M | 67 | 13 ans | |
Jonathan Silverstein | M | 57 | 5 ans | |
Jennifer Jarrett | F | 53 | 3 ans | |
Tracy M. Porter | F | - | 1 ans | |
Toru Yoshimitsu | M | 61 | - | |
Masaaki Hirano | M | 57 | - | |
Catherine Parham | M | - | - | |
Andrew H. Chang | M | - | - | |
Maria Lopez | F | - |
Cytovance Biologics, Inc.
![]() Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | - |
Jeffrey Su | M | - |
Cytovance Biologics, Inc.
![]() Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | 4 ans |
Suyash Prasad | M | 54 | 5 ans | |
John T. Gray | M | 60 | 5 ans | |
Mark Meltz | M | 50 | 1 ans | |
Eric B. Mosbrooker | M | 46 | 2 ans | |
Don Wuchterl | M | - |
Cytovance Biologics, Inc.
![]() Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | - |
Sarah Spencer | F | - | 2 ans | |
Percival Barretto-Ko | M | 51 | - | |
David Nagler | M | 71 | 5 ans | |
Scott Nogi | M | - | 4 ans | |
Jason O’Byrne | M | 55 | 2 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 50 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Donald Wuchterl
- Réseau Personnel